The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Integrative analysis of KRAS-wildtype pancreatic ductal adenocarcinoma reveals unique similarities to extrahepatic cholangiocarcinoma.
 
Erica S Tsang
No Relationships to Disclose
 
James T. Topham
No Relationships to Disclose
 
Joanna Karasinska
No Relationships to Disclose
 
Steve Kalloger
No Relationships to Disclose
 
Veronika Csizmok
No Relationships to Disclose
 
Laura Williamson
No Relationships to Disclose
 
Hui-Li Wong
Stock and Other Ownership Interests - Oncosil (I)
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - MSD
 
Grainne M. O'Kane
Honoraria - AstraZeneca; Eisai; Roche
Consulting or Advisory Role - Eisai; Roche
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
 
Jonathan M. Loree
Consulting or Advisory Role - AMGEN; Bayer; Eisai; Ipsen; Novartis; Pfizer; Taiho Pharmaceutical
Research Funding - Amgen (Inst); Ipsen (Inst)
 
Faiyaz Notta
No Relationships to Disclose
 
Oliver F. Bathe
No Relationships to Disclose
 
Patricia A. Tang
No Relationships to Disclose
 
Rachel Anne Goodwin
Honoraria - Advanced Accelerator Applications; Advanced Accelerator Applications; Eisai; Ipsen; Pfizer
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Amgen; Apobiologix; Eisai; Incyte; Ipsen; Merck; Pfizer; Taiho Pharmaceutical
Speakers' Bureau - Advanced Accelerator Applications/Novartis; Eisai; Merck; Mylan; Novartis; Pfizer
Research Funding - Eisai; Ipsen
 
Jennifer J. Knox
Honoraria - AstraZeneca; Roche Canada
Consulting or Advisory Role - AstraZeneca/MedImmune; Ipsen; Lilly; Merck
Research Funding - AstraZeneca; Ipsen; Merck
Expert Testimony - AstraZeneca
 
Steven Gallinger
No Relationships to Disclose
 
Janessa J. Laskin
Honoraria - AstraZeneca; Pfizer; Roche Canada
Consulting or Advisory Role - Amgen; Roche Canada; Takeda
Research Funding - AstraZeneca (Inst); Lilly (Inst); Roche Canada (Inst)
 
Marco A. Marra
No Relationships to Disclose
 
Steven J. M. Jones
No Relationships to Disclose
 
David F. Schaeffer
No Relationships to Disclose
 
Daniel John Renouf
Honoraria - Celgene; Ipsen; Roche; SERVIER; Taiho Pharmaceutical
Consulting or Advisory Role - AstraZeneca; Celgene; SERVIER; Shire; Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst); Bayer (Inst)